Signals
Desmoid Tumours Are Not Benign to the People Living With Them
FDA has accepted Immunome’s NDA for varegacestat in adults with progressing desmoid tumours. The label may say non-metastatic. The burden can still be brutal.
When Dementia Takes Speech, Trials Must Catch Up
Child Mental Health Access Still Depends on the Facility
Europe Built Seasonal COVID Campaigns. Most Older Adults Were Not Reached.
Treating hypertension in pregnancy is possible. Making it routine care is the policy challenge
Ultra-processed food may leave a metabolic fingerprint in the blood.
Huntington’s Gets Another Chance at Proof
New global heart failure definition exposes a policy gap: systems still diagnose too late and treat too narrowly
Sugar substitutes were sold as metabolic shortcuts. The evidence is getting harder to ignore
Early Lung Cancer Just Became a Biomarker Test of the System
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.